Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Alcresta Therapeutics, Inc. See All Filings	D	2020-03-03 13:46:00 UTC
Amount To Be Raised $19,999,998 Associated Brokers / Dealers N/A CIK Number 0001673510 Filed Document 0001673510-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-03-03 13:46:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Alcresta Therapeutics, Inc. See All Filings	D	2019-01-23 10:51:16 UTC
Amount To Be Raised $25,000,000 Associated Brokers / Dealers N/A CIK Number 0001673510 Filed Document 0001673510-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-01-23 10:51:16 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Alcresta Therapeutics, Inc. See All Filings	D	2017-09-25 14:42:43 UTC
Amount To Be Raised $34,999,978 Associated Brokers / Dealers N/A CIK Number 0001673510 Filed Document 0001673510-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-09-25 14:42:43 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Alcresta Therapeutics, Inc. See All Filings	D/A	2016-10-31 16:43:21 UTC
Amount To Be Raised $50,889,675 Associated Brokers / Dealers N/A CIK Number 0001673510 Filed Document 0001140361-16-084182 Exclusions or Exemptions 506b Accepted Date 2016-10-31 16:43:21 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Alcresta, Inc. See All Filings	D	2016-06-14 15:56:31 UTC
Amount To Be Raised $49,389,680 Associated Brokers / Dealers N/A CIK Number 0001673510 Filed Document 0001140361-16-069707 Exclusions or Exemptions 506b Accepted Date 2016-06-14 15:56:31 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity